SG11201913517UA - Improved process for preparing aminopyrimidine derivatives - Google Patents

Improved process for preparing aminopyrimidine derivatives

Info

Publication number: SG11201913517UA
Authority: SG; Singapore
Prior art keywords: improved process; aminopyrimidine derivatives; preparing; preparing aminopyrimidine; derivatives
Prior art date: 2017-07-28

Application number

SG11201913517UA

Inventor

Sang-Ho Oh

Ja-Heouk Khoo

Jong-Chul Lim

Seong-Ran Lee

Hyun Ju

Woo-Seob Shin

Dae-Gyu Park

su-min Park

Yoon-Ah Hwang

Original Assignee

Yuhan Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-07-28

Filing date

2018-07-25

Publication date

2020-02-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65040211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201913517U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-07-25 Application filed by Yuhan Corp filed Critical Yuhan Corp

2020-02-27 Publication of SG11201913517UA publication Critical patent/SG11201913517UA/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2284—Compounds with one or more Sn-N linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Catalysts (AREA)

SG11201913517UA 2017-07-28 2018-07-25 Improved process for preparing aminopyrimidine derivatives SG11201913517UA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR20170096212		2017-07-28
PCT/KR2018/008379 WO2019022485A1 (en)	2017-07-28	2018-07-25	Improved process for preparing aminopyrimidine derivatives

Publications (1)

Publication Number	Publication Date
SG11201913517UA true SG11201913517UA (en)	2020-02-27

Family

ID=65040211

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201913517UA SG11201913517UA (en)	2017-07-28	2018-07-25	Improved process for preparing aminopyrimidine derivatives

Country Status (30)

Country	Link
US (4)	US10889578B2 (en)
EP (1)	EP3658552B1 (en)
JP (2)	JP7228562B2 (en)
KR (1)	KR102688084B1 (en)
CN (2)	CN116987112A (en)
AU (2)	AU2018308038B2 (en)
BR (1)	BR112020001278A2 (en)
CA (1)	CA3070069C (en)
CO (1)	CO2020000374A2 (en)
DK (1)	DK3658552T3 (en)
EA (1)	EA202090383A1 (en)
ES (1)	ES2962961T3 (en)
FI (1)	FI3658552T3 (en)
HR (1)	HRP20231191T1 (en)
HU (1)	HUE063533T2 (en)
IL (2)	IL271973B (en)
LT (1)	LT3658552T (en)
MA (1)	MA49700B1 (en)
MD (1)	MD3658552T2 (en)
MX (1)	MX2022008743A (en)
PH (1)	PH12020500059A1 (en)
PL (1)	PL3658552T3 (en)
PT (1)	PT3658552T (en)
RS (1)	RS64654B1 (en)
SA (1)	SA520411112B1 (en)
SG (1)	SG11201913517UA (en)
SI (1)	SI3658552T1 (en)
UA (1)	UA125317C2 (en)
WO (1)	WO2019022485A1 (en)
ZA (1)	ZA202001250B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2962961T3 (en) *	2017-07-28	2024-03-22	Yuhan Corp	Preparation procedure of n-(5-((4-(4-(dimethylamino)methyl)-3-phenyl-1h-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl )acrylamide by reacting the corresponding amine with a 3-halo-propionyl chloride
WO2020230091A1 (en)	2019-05-14	2020-11-19	Janssen Biotech, Inc.	Combination therapies with bispecific anti-egfr/c-met antibodies and third generation egfr tyrosine kinase inhibitors
US11850248B2 (en) *	2019-05-14	2023-12-26	Yuhan Corporation	Therapies with 3rd generation EGFR tyrosine kinase inhibitors
US11780824B2 (en) *	2020-12-16	2023-10-10	Scinopharm Taiwan, Ltd.	Process for preparing osimertinib or a salt thereof
CN116199701A (en) *	2023-02-27	2023-06-02	安徽中医药大学	Pyrazolooxazinone compound prepared based on intramolecular free radical cycloaddition and preparation method thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5721237A (en)	1991-05-10	1998-02-24	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
MXPA04004969A (en)	2001-11-27	2004-08-11	Wyeth Corp	3-cyanoquinolines as inhibitors of egf-r and her2 kinases.
GB0305929D0 (en)	2003-03-14	2003-04-23	Novartis Ag	Organic compounds
JP2008520612A (en)	2004-11-24	2008-06-19	ノバルティスアクチエンゲゼルシャフト	Combination of JAK inhibitor and at least one of Bcr-Abl, Flt-3, FAK or RAF kinase inhibitor
US20060270600A1 (en)	2005-05-26	2006-11-30	Eisuke Mekada	Anti-cancer agents
TW200736232A (en)	2006-01-26	2007-10-01	Astrazeneca Ab	Pyrimidine derivatives
CL2007003049A1 (en)	2006-10-23	2008-05-16	Cephalon Inc Pharmacopeia Drug	COMPOUNDS DERIVED FROM 2,4-DIAMINOPIRIMIDINE; PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT PROLIFERATIVE DISORDERS.
TW200840581A (en)	2007-02-28	2008-10-16	Astrazeneca Ab	Novel pyrimidine derivatives
WO2008124085A2 (en)	2007-04-03	2008-10-16	Exelixis, Inc.	Methods of using combinations of mek and jak-2 inhibitors
JP2011526299A (en) *	2008-06-27	2011-10-06	アビラセラピューティクス，インコーポレイテッド	Heteroaryl compounds and their use
MX2012004313A (en)	2009-10-12	2012-07-20	Myrexis Inc	Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon.
WO2011060295A1 (en)	2009-11-13	2011-05-19	Genosco	Kinase inhibitors
JP5802676B2 (en)	2009-12-04	2015-10-28	センワバイオサイエンシズインコーポレイテッド	Pyrazolopyrimidines and related heterocyclic compounds as CK2 inhibitors
PE20140192A1 (en)	2010-10-06	2014-02-24	Glaxosmithkline Llc	BENZHIMIDAZOLE DERIVATIVES AS KINASE PI3 INHIBITORS
WO2012061303A1 (en)	2010-11-01	2012-05-10	Avila Therapeutics, Inc.	Heteroaryl compounds and uses thereof
MY172110A (en)	2010-12-13	2019-11-14	Array Biopharma Inc	Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors
RS62542B1 (en) *	2011-07-27	2021-12-31	Astrazeneca Ab	2-(2,4,5-substituted-anilino)pyrimidine compounds
JP2015503505A (en)	2011-12-23	2015-02-02	ミレニアムファーマシューティカルズ，インコーポレイテッドＭｉｌｌｅｎｎｉｕｍＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	Heteroaryl and uses thereof
WO2013100632A1 (en)	2011-12-30	2013-07-04	Hanmi Pharm Co., Ltd.	THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
CN104860891B (en)	2014-02-25	2017-06-30	上海海雁医药科技有限公司	Fragrant amino pyrimidines and its application and pharmaceutical composition prepared therefrom and Pharmaceutical composition
JP6468611B2 (en)	2014-05-13	2019-02-13	アリアドファーマシューティカルズ，インコーポレイテッド	Heteroaryl compounds for kinase inhibition
WO2015188777A1 (en)	2014-06-12	2015-12-17	Shanghai Fochon Pharmaceutical Co Ltd	Certain protein kinase inhibitors
KR102487451B1 (en)	2014-10-13	2023-01-11	주식회사유한양행	Compounds and compositions for modulating egfr mutant kinase activities
CN104788427B (en)	2015-02-05	2017-05-31	上海泓博智源医药股份有限公司	3 (2 pyrimdinyl-amino) phenylacryloyl amine compounds and its application
AR102263A1 (en)	2015-10-14	2017-02-15	Yuhan Corp	COMPOUNDS AND COMPOSITIONS FOR THE MODULATION OF THE KINASA ACTIVITIES OF THE RECEIVER OF EGF MUTANTE
DE102017212159A1 (en)	2017-07-14	2019-01-17	Krones Aktiengesellschaft	Method and device for handling piece goods, articles and / or containers
CA3070070A1 (en) *	2017-07-28	2019-01-31	Yuhan Corporation	Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same
ES2962961T3 (en) *	2017-07-28	2024-03-22	Yuhan Corp	Preparation procedure of n-(5-((4-(4-(dimethylamino)methyl)-3-phenyl-1h-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl )acrylamide by reacting the corresponding amine with a 3-halo-propionyl chloride
CN108826170A (en)	2018-06-26	2018-11-16	深圳市远润欣电子有限公司	Mode, control method and the desk lamp of localized general lighting

2018
- 2018-07-25 ES ES18837360T patent/ES2962961T3/en active Active
- 2018-07-25 PT PT188373609T patent/PT3658552T/en unknown
- 2018-07-25 MD MDE20200593T patent/MD3658552T2/en unknown
- 2018-07-25 HU HUE18837360A patent/HUE063533T2/en unknown
- 2018-07-25 RS RS20230834A patent/RS64654B1/en unknown
- 2018-07-25 PL PL18837360.9T patent/PL3658552T3/en unknown
- 2018-07-25 CN CN202310702453.8A patent/CN116987112A/en active Pending
- 2018-07-25 BR BR112020001278-5A patent/BR112020001278A2/en unknown
- 2018-07-25 CN CN201880048638.9A patent/CN111315742B/en active Active
- 2018-07-25 UA UAA202001303A patent/UA125317C2/en unknown
- 2018-07-25 EA EA202090383A patent/EA202090383A1/en unknown
- 2018-07-25 KR KR1020180086376A patent/KR102688084B1/en active IP Right Grant
- 2018-07-25 JP JP2020504203A patent/JP7228562B2/en active Active
- 2018-07-25 AU AU2018308038A patent/AU2018308038B2/en active Active
- 2018-07-25 IL IL271973A patent/IL271973B/en unknown
- 2018-07-25 SG SG11201913517UA patent/SG11201913517UA/en unknown
- 2018-07-25 US US16/633,684 patent/US10889578B2/en active Active
- 2018-07-25 MA MA49700A patent/MA49700B1/en unknown
- 2018-07-25 CA CA3070069A patent/CA3070069C/en active Active
- 2018-07-25 HR HRP20231191TT patent/HRP20231191T1/en unknown
- 2018-07-25 DK DK18837360.9T patent/DK3658552T3/en active
- 2018-07-25 SI SI201830998T patent/SI3658552T1/en unknown
- 2018-07-25 LT LTEPPCT/KR2018/008379T patent/LT3658552T/en unknown
- 2018-07-25 FI FIEP18837360.9T patent/FI3658552T3/en active
- 2018-07-25 WO PCT/KR2018/008379 patent/WO2019022485A1/en active Application Filing
- 2018-07-25 MX MX2022008743A patent/MX2022008743A/en unknown
- 2018-07-25 EP EP18837360.9A patent/EP3658552B1/en active Active
2020
- 2020-01-07 PH PH12020500059A patent/PH12020500059A1/en unknown
- 2020-01-15 CO CONC2020/0000374A patent/CO2020000374A2/en unknown
- 2020-01-21 SA SA520411112A patent/SA520411112B1/en unknown
- 2020-02-27 ZA ZA2020/01250A patent/ZA202001250B/en unknown
- 2020-12-08 US US17/115,037 patent/US11286253B2/en active Active
2022
- 2022-03-25 US US17/704,718 patent/US11708362B2/en active Active
- 2022-04-24 IL IL292429A patent/IL292429B2/en unknown
- 2022-05-03 AU AU2022202936A patent/AU2022202936B2/en active Active
- 2022-11-18 JP JP2022184867A patent/JP7539451B2/en active Active
2023
- 2023-06-02 US US18/328,267 patent/US20230312545A1/en active Pending

Also Published As

Publication number	Publication date
JP2020528440A (en)	2020-09-24
PL3658552T3 (en)	2024-02-19
ES2962961T3 (en)	2024-03-22
KR102688084B1 (en)	2024-07-24
JP2023027091A (en)	2023-03-01
MA49700A (en)	2021-03-17
US11286253B2 (en)	2022-03-29
EP3658552B1 (en)	2023-09-13
LT3658552T (en)	2023-11-27
AU2022202936A1 (en)	2022-05-26
HRP20231191T1 (en)	2024-02-02
SA520411112B1 (en)	2022-02-21
CA3070069A1 (en)	2019-01-31
UA125317C2 (en)	2022-02-16
RS64654B1 (en)	2023-10-31
SI3658552T1 (en)	2023-11-30
FI3658552T3 (en)	2023-11-16
MX2022008743A (en)	2023-02-02
PH12020500059A1 (en)	2020-09-28
JP7228562B2 (en)	2023-02-24
ZA202001250B (en)	2023-04-26
CO2020000374A2 (en)	2020-05-05
US20210269427A1 (en)	2021-09-02
AU2018308038B2 (en)	2022-02-03
US10889578B2 (en)	2021-01-12
PT3658552T (en)	2023-11-03
US20230312545A1 (en)	2023-10-05
CN111315742B (en)	2023-09-01
CA3070069C (en)	2024-02-20
NZ761156A (en)	2024-01-26
KR20190013553A (en)	2019-02-11
IL292429A (en)	2022-06-01
EP3658552A1 (en)	2020-06-03
EA202090383A1 (en)	2020-06-15
JP7539451B2 (en)	2024-08-23
IL271973B (en)	2022-08-01
AU2018308038A1 (en)	2020-01-30
IL271973A (en)	2020-02-27
EP3658552A4 (en)	2021-06-23
US20200165236A1 (en)	2020-05-28
DK3658552T3 (en)	2023-11-20
IL292429B1 (en)	2023-05-01
MA49700B1 (en)	2023-09-27
WO2019022485A1 (en)	2019-01-31
CN116987112A (en)	2023-11-03
CN111315742A (en)	2020-06-19
BR112020001278A2 (en)	2020-07-21
MD3658552T2 (en)	2024-02-29
AU2022202936B2 (en)	2023-04-27
US11708362B2 (en)	2023-07-25
IL292429B2 (en)	2023-09-01
HUE063533T2 (en)	2024-01-28
US20220281861A1 (en)	2022-09-08

Publication	Publication Date	Title
ZA201708142B (en)	2019-05-29	Process for preparing 4-amino-pyridazines
PL3325443T3 (en)	2022-08-01	Process for preparing pridopidine
IL274439A (en)	2020-06-30	Process for preparing tapinarof
IL292429B2 (en)	2023-09-01	Improved process for preparing aminopyrimidine derivatives
IL275216A (en)	2020-07-30	Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives
SI3526229T1 (en)	2021-08-31	Process for preparing glucopyranosyl-substituted benzyl-benzene derivatives
HUE053818T2 (en)	2021-07-28	Process for preparing hmf
IL253877B (en)	2020-03-31	Process for preparing 3-chloro-2-vinylphenylsulfonates
PL3573988T3 (en)	2023-05-08	Process for preparing purine derivatives
ZA201801650B (en)	2019-05-29	Process for producing novel 4-benzoazonine derivatives
EP3444253A4 (en)	2019-09-11	Process for preparing ad-35
ZA201908452B (en)	2022-03-30	Improved process for preparing imetelstat
IL248568B (en)	2019-03-31	Process for preparing dihydroisoxazole derivatives
IL273639A (en)	2020-05-31	Process for preparing alpha-carboxamide pyrolidine derivatives
IL273695A (en)	2020-05-31	Process for preparing spiro derivatives
IL271512B (en)	2022-03-01	Method for preparing substituted 4-aminoindane derivatives
IL253630B (en)	2019-11-28	Process for preparing substituted phenylisoxazoline derivatives
SG11201709830YA (en)	2018-05-30	Process for preparing carbazoles